Scilex (SCLXW) Competitors $0.10 -0.05 (-31.84%) As of 03/27/2025 02:26 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock SCLXW vs. ATNFW, SXTPW, AARD, ACONW, AIMDW, DRTSW, ALVOW, AONCW, AONC, and WENAWShould you be buying Scilex stock or one of its competitors? The main competitors of Scilex include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aardvark Therapeutics (AARD), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), American Oncology Network (AONCW), American Oncology Network (AONC), and Anew Medical (WENAW). These companies are all part of the "medical" sector. Scilex vs. 180 Life Sciences 60 Degrees Pharmaceuticals Aardvark Therapeutics Aclarion Ainos Alpha Tau Medical Alvotech American Oncology Network American Oncology Network Anew Medical 180 Life Sciences (NASDAQ:ATNFW) and Scilex (NASDAQ:SCLXW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings, valuation and community ranking. Which has better earnings & valuation, ATNFW or SCLXW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AScilex$55.15MN/AN/AN/AN/A Is ATNFW or SCLXW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Scilex N/A N/A N/A Does the media favor ATNFW or SCLXW? In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.89 beat Scilex's score of 0.64 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Very Positive Scilex Positive Does the MarketBeat Community favor ATNFW or SCLXW? 180 Life Sciences and Scilex both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/AScilexN/AN/A Summary180 Life Sciences and Scilex tied by winning 1 of the 2 factors compared between the two stocks. Remove Ads Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLXW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCLXW vs. The Competition Export to ExcelMetricScilexDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$99.44B$5.64B$8.06BDividend YieldN/A2.47%4.56%4.02%P/E RatioN/A24.8223.1319.03Price / SalesN/A171.54383.8993.17Price / CashN/A17.5938.1634.64Price / BookN/A3.156.944.33Net IncomeN/A$3.43B$3.20B$247.06M7 Day PerformanceN/A-3.11%-2.30%-0.52%1 Month PerformanceN/A-0.34%3.10%-3.73%1 Year Performance-74.95%-5.91%11.22%1.74% Scilex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCLXWScilexN/A$0.10-31.8%N/A-75.0%$0.00$55.15M0.00105News CoverageGap DownATNFW180 Life SciencesN/A$0.01+6.0%N/A-16.2%$0.00N/A0.007SXTPW60 Degrees PharmaceuticalsN/A$0.03flatN/A-81.5%$0.00$502,409.000.002Positive NewsAARDAardvark TherapeuticsN/A$9.21-2.2%$30.50+231.2%N/A$0.00N/A0.0018Analyst ForecastQuiet Period ExpirationNews CoverageGap DownACONWAclarionN/A$0.05-18.3%N/A-24.8%$0.00$49,289.000.007News CoverageGap DownAIMDWAinosN/A$0.17+29.6%N/A+1.6%$0.00$20,729.000.0040Gap DownDRTSWAlpha Tau MedicalN/A$0.23-1.8%N/A-16.3%$0.00N/A0.0080Gap DownALVOWAlvotechN/A$2.03+9.1%N/A-43.3%$0.00$391.87M0.004Short Interest ↓Positive NewsGap DownAONCWAmerican Oncology NetworkN/A$0.28+21.7%N/A-22.7%$0.00$1.34B0.001,525Gap DownAONCAmerican Oncology NetworkN/A$5.60-3.1%N/A-15.3%$0.00$1.34B0.001,520Gap DownWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap Down Remove Ads Related Companies and Tools Related Companies ATNFW Competitors SXTPW Competitors AARD Competitors ACONW Competitors AIMDW Competitors DRTSW Competitors ALVOW Competitors AONCW Competitors AONC Competitors WENAW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SCLXW) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scilex Holding Please log in to your account or sign up in order to add this asset to your watchlist. Share Scilex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SCLXW Stock Free SCLXW Stock Alerts